pediatric cancer

Personalized medicine: Right drug, right patient, right time
Personalized medicine: Right drug, right patient, right timeThe premise is to use a patient’s own genetic information to guide decisions for prevention, diagnosis, and treatment of disease and other health conditions.
Pediatric high-grade glioma is not one tumor type but manyStratifying tumors by their clinical characteristics and underlying biology will enable future targeting of specific therapies for glioma in children.
Personalized and costly, but new ALL treatment offers hopeA new customized therapy for acute lymphoblastic leukemia (ALL) offers high remission rates but at a substantial cost, and only at specialized cancer centers.
The price of surviving childhood cancerSurviving cancer is challenging enough, but now a recent report highlights the fact that survivors face double the chronic health challenges of the general population as a result of curative cancer therapies.
Why do so many kids die so soon following a cancer diagnosis?While improvements have been made to childhood cancer mortality rates, a recent research study aims to identify how many children die before being able to start treatment, and what interventions can be put in place to improve their chances.
Boy with ear pain and facial weaknessA 13-year-old boy with poorly controlled type 1 diabetes (T1D) presents to the emergency department (ED) for evaluation of left ear pain and left facial weakness.
Reimagineering chemotherapyFun isn’t what you’d typically expect in a chemotherapy infusion room. Yet, that’s precisely the environment an adolescent and young adult oncologist and a former Disney Imagineer created with the Infusionarium concept.
Clinical acumen key for identifying pediatric melanomaExperts discuss diagnosis and management of pediatric melanoma, including the latest developments in genetic tools and indications for sentinel lymph node biopsy.
Technology innovation drives better outcomes in pediatricsA look at some of the technology advances at one hospital, and across the country, that are changing the way pediatric cancer patients are treated.
Lab, clinical background key in pediatric dermatopathologyEven with relatively recent advances such as immunohistochemical staining and molecular analysis, experts say, pediatric dermatopathology relies heavily on clinical correlation.